Elsevier MDL introduces MDL® Notebook
News Dec 19, 2005
Elsevier MDL has delivered ahead of schedule the initial release of a major electronic lab notebook (ELN) initiative announced in March 2005. MDL® Notebook gives scientists a central hub to simplify their work, capture data, document processes and make essential information available throughout a research organization.
Additional releases planned for 2006 and beyond will expand capabilities for scientific disciplines, building on MDL informatics and integration strengths to deliver comprehensive workflow solutions for researchers.
"Scientists - particularly chemists - traditionally fill paper notebooks with vital information that is very difficult to effectively capture and disseminate," said Trevor Heritage, Senior Vice President, Workflow Business Group, Elsevier MDL.
"MDL Notebook brings systematic efficiency to fundamental research activity by streamlining workflows, improving productivity and integrating information throughout R&D organizations. Elsevier MDL's expertise in reaction databases and experience with custom electronic notebooks contribute to a comprehensive system that is unrivaled in integration capabilities, chemistry know-how and IT performance."
MDL Notebook provides scientists with a hub for total workflow integration. From the MDL Notebook, scientists can store experiment protocols, share hypotheses with colleagues and legally document discoveries. The system streamlines workflows, automates repetitive tasks and allows scientists to easily create reports and collaborate.
They can search corporate, third-party and in-house databases and perform reaction transformation searches, to immediately access relevant information in useful context.
Synthetic chemists can utilize tools for single and multi-step reactions and discrete and parallel synthesis and reaction information is captured in a true reaction database that supports reaction substructure searches.
Many life-saving medicines, including insulin, antibodies and vaccines, are derived from living cells. These “biologics” can be difficult to obtain and store on the battlefield or in remote areas. That’s why scientists are trying to develop portable systems that can quickly manufacture small batches of protein therapeutics on demand.READ MORE
Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress
Oct 24 - Oct 26, 2019